Soc. Generale Knock-Out PGR/ DE000SY41Z69 /
8/30/2024 8:45:00 PM | Chg.+0.11 | Bid9:09:58 PM | Ask9:09:58 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.18EUR | +10.28% | 1.19 Bid Size: 30,000 |
1.21 Ask Size: 30,000 |
Progressive Corporat... | 238.6632 USD | 12/31/2078 | Call |
GlobeNewswire
8/19
Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa
GlobeNewswire
8/19
Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief ...
GlobeNewswire
8/15
Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement o...
GlobeNewswire
8/14
Atsena Therapeutics Receives Rare Pediatric Disease Designation from the U.S. FDA for ATSN-201 Gene ...
GlobeNewswire
8/14
Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
GlobeNewswire
8/13
Eyenovia to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
GlobeNewswire
8/12
Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Newsfile Corp
8/12
The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
GlobeNewswire
8/8
Opthea to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference, August 15,...
GlobeNewswire
8/7
Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Sus...
GlobeNewswire
8/7
AGS Unveils its Latest Table Innovation Bonus Spin Xtreme for Poker Rooms and an Exciting New Lineup...
GlobeNewswire
8/7
Team, Inc. Announces Timing of Second Quarter Earnings Release and Conference Call
GlobeNewswire
8/6
TG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy)...
GlobeNewswire
8/6
Levicept Announces Positive Results of Phase II Trial of novel Neurotrophin-3 Inhibitor, LEVI-04, fo...
GlobeNewswire
8/5
NeOnc Technologies Begins Enrollment for Phase 2 Clinical Trial of NEO100-02™ for Patients Afflicted...